The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLms Capital Regulatory News (LMS)

Share Price Information for Lms Capital (LMS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.05
Bid: 17.90
Ask: 18.60
Change: 0.00 (0.00%)
Spread: 0.70 (3.911%)
Open: 18.05
High: 0.00
Low: 0.00
Prev. Close: 18.05
LMS Live PriceLast checked at -
LMS Capital is an Investment Trust

To achieve absolute total returns over the medium to longer term, principally through capital gains and supplemented with the generation of a longer term income yield, by investing primarily in private equity.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Net Asset Value(s) 3rd Quarter 2020 update

28 Oct 2020 07:00

RNS Number : 3998D
LMS Capital PLC
28 October 2020
 

 

 

28 October 2020

 

 

 

LMS Capital plc

Third Quarter 2020 Update

 

 

LMS Capital plc ("LMS" or "the Company"), the investment company, is issuing the following update covering the period from 1 July 2020 to date.

 

Financial Highlights

• Unaudited Net Asset Value ("NAV") at 30 September 2020 was £47.0 million (58.2p per share). This compares to £46.5 million (57.6p per share) at 30 June 2020;

• At the half year the Company announced the initiation of a progressive annual dividend policy targeting a dividend equal to approximately 1.5% of each financial year's closing NAV, subject to the Company's liquidity, investment income generated, distributable profits and market conditions. The first interim dividend under this policy, of £0.2 million (£0.3p per share) was paid to shareholders in September 2020;

• Cash at 30 September was £22.0 million. This is after having funded £7.0 million of cash for its previously announced $9 million investment in Dacian petroleum ("Dacian") - see below.

 

Investment in Dacian

• On 12 August 2020 the Company announced that it was leading an investor group which has conditionally agreed to finance the acquisition by Dacian from OMV Petrom, the Romanian oil company, of a business operating 40 onshore oil and gas fields located in Romania;

• Completion of the acquisition by Dacian is conditional upon Dacian obtaining certain Romanian Government regulatory approvals. During September, in accordance with the investment agreement, the investor group were called to deposit funds to be held pending conclusion of the approval process;

• The Dacian team has reported to the investor group that, whilst not yet completed, the approval process is proceeding well and it is their current expectation that the necessary approvals will be obtained and the transaction will complete before the current contractual backstop date in early January 2021; and

• LMS will provide a further update to the market once the approval process is completed.

 

Unaudited Net Asset Value at 30 September 2020

The increase in the NAV over the quarter arises from £1.7 million of unrealised gains on the investment portfolio, offset by £0.5 million of portfolio foreign exchange losses from the weakening of the US Dollar against the sterling, overheads of £0.4 million and other non-portfolio foreign exchange losses of £0.1 million.

 

 

The 30 September 2020 NAV is summarised below:

 

Unaudited

30 June 2020

 

Unaudited

30 September 2020

£ millions

Quoted Investments

0.5

0.4

Unquoted Investments

8.8

8.3

Funds

10.0

10.8

Subtotal Investment portfolio

19.3

19.5

Cash

29.0

22.0

Dacian Investment - Funds Deposited

-

7.0

Other Net Assets/Liabilities

(1.8)

(1.5)

Net Asset Value

46.5

47.0

 

The NAV at the end of September is based on the valuation of the Company's investments as at 30 June 2020, adjusted for transactions in the three months ended 30 September 2020, price movements on quoted securities, movements in foreign currency exchange rates, cash calls and distributions from funds, and latest information from third party fund managers.

 

The following table summarises the change in NAV for the third quarter:

 

£ millions

Unaudited NAV as at 30 June 2020

 £ 46.5

Unrealised Portfolio Gains

1.7

Unrealised Portfolio Foreign Exchange Losses

(0.5)

Overheads

(0.4)

Unrealised Other Foreign Exchange Losses

(0.1)

Interim Dividend

(0.2)

Unaudited NAV as at 30 September 2020

 £ 47.0

 

 

The portfolio net unrealised gains of £1.7 million,excluding foreign exchange movements, are summarised below.

Quoted Investments

The Company's quoted investment valuations reduced by a net £0.2 million during the third quarter of 2020. This comprised unrealised underlying market price reductions of £0.2 million during the quarter, primarily from a decline in the market price of IDE Group Holdings plc.

 

Unquoted Investments

The Company's unquoted investments include assets managed by SFEP, YesTo and ICU Eyewear, and our direct holdings in Medhost, Elateral and Northbridge Industrial Services plc.

 

Total unquoted investment unrealised gains were £0.7 million for the quarter. Primus Capital, the lead fund manager on Medhost, increased its latest valuation resulting in an unrealised gain of £0.6 million for the third quarter on the Company's holding in Medhost. Other net gains were £0.1 million.

 

Funds

The Company's fund investments include its holding in Brockton Capital Fund 1, Opus Capital and three other smaller fund interests.

 

Total fund unrealised gains were £1.2 million for the third quarter as fund valuations increased, primarily from Opus, and an escrow distribution from a previous exit. The carrying value of the funds is based on the latest information from the respective fund managers, generally the 30 June 2020 fund valuation reports.

 

Portfolio Realisations

Realisations from the portfolio during the quarter were £1.0 million, comprising a loan repayment from ICU Eyewear of £0.8 million plus other fund distributions and escrow proceeds of £0.2 million from a previous exit.

 

Liquidity and Outlook

The Company continues to maintain significant cash balances, £22.0 million at 30 September, after depositing cash to fund the Dacian transaction, and remains highly cautious about the way its liquid resources are deployed.

 

The Company is reviewing opportunities with its real estate teams, George Capital and Cavera, but capital has not yet been deployed. The Company has a pipeline of opportunities for other investments.

 

Movements in prices of quoted securities and foreign exchange rates since 30 September 2020 have not been material.

 

The information contained in this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon publication of this announcement, this inside information is now considered to be in the public domain.

 

 

 

 

 

 

For further information, please contact:

 

LMS Capital PLC

 

Robert Rayne, Chairman

Nick Friedlos, Managing Director

 

Tel +44 207 935 3555; +44 7802 686584

 

Shore Capital

 

Robert Finlay

 

Tel +44 207 408 4050

 

 

Notes to Editors

 

LMS Capital plc is a fully listed investment company which aims to preserve and create wealth through investment and co-investment from family offices, high net worth investors and others. LMS expects to deliver an overall total return, net of costs, over the longer term of 12%-15% per annum, of which an element will include an annual distribution.

 

LMS focuses on investing in real estate, energy and late-stage private equity, areas in which the company has had demonstrable success for over 40 years, derived from a long history of investing, a depth of understanding and long-term relationships.

 

LMS works with experienced management teams to deliver exceptional opportunities and 'hard to access' assets not available via larger funds, enabling wealth creation through nurturing and careful management. LMS' philosophy of co-investment has led to the establishment of a formal network of partners, LMS Co-invest Co., which is a wholly owned subsidiary and is resourced to develop co-investment relationships and activity. This model harnesses experience, capital and access to specialist investment teams to create enhanced returns.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVMZMZGLNMGGZM
Date   Source Headline
24th Apr 20244:42 pmRNSNotice of AGM
19th Mar 20247:00 amRNS2023 Final Results
8th Mar 20242:23 pmRNSHolding(s) in Company
23rd Feb 20247:00 amRNSNet Asset Value(s)
29th Jan 20247:00 amRNSPortfolio Update - Brockton Fund 1
27th Dec 20237:00 amRNSPortfolio Update
21st Dec 20237:00 amRNSRetirement living investment platform
30th Oct 20237:00 amRNSThird Quarter 2023 Update
16th Aug 20233:11 pmRNSLong Term Incentive Plan Awards
1st Aug 20237:00 amRNSHalf year results for the 6 months ended 30.06.23
23rd May 20234:03 pmRNSDividend Declaration - REPLACEMENT
18th May 20234:08 pmRNSDividend Declaration
18th May 20234:03 pmRNSResult of AGM
5th May 20237:00 amRNSStatement re Notice to shareholders
28th Apr 20237:00 amRNSFirst Quarter 2023 Update
24th Apr 20232:42 pmRNSNotice of AGM
24th Apr 20232:37 pmRNSNotice of AGM
14th Apr 202310:47 amRNSHolding(s) in Company
22nd Mar 20233:04 pmRNSHolding(s) in Company
20th Mar 20237:00 amRNSFinal Results fo rthe Year Ended 31 December 2022
7th Feb 20237:00 amRNSNet Asset Value(s)
25th Nov 20223:54 pmRNSHolding(s) in Company
28th Oct 20227:00 amRNSThird Quarter 2022 Update
2nd Aug 20227:09 amRNSHalf year Report and Dividend declaration
19th May 20223:42 pmRNSDividend Declaration
18th May 20224:27 pmRNSResult of AGM
27th Apr 20227:00 amRNSFirst Quarter 2022 Update
22nd Apr 20227:00 amRNSNotice of Annual General Meeting 2022
10th Mar 20227:00 amRNSFinal Results for the Year Ended 31 December 2021
31st Jan 20227:00 amRNSNAV Estimate as at 31 December 2021
15th Dec 20214:41 pmRNSSecond Price Monitoring Extn
15th Dec 20214:36 pmRNSPrice Monitoring Extension
23rd Nov 20217:00 amRNSPortfolio Update
12th Nov 202112:34 pmRNSPortfolio Update
22nd Oct 20217:00 amRNSThird Quarter 2021 Update
23rd Sep 202112:16 pmRNSHolding(s) in Company
4th Aug 20217:00 amRNSDividend Declaration
3rd Aug 20217:00 amRNSHalf-year Report
8th Jul 202110:16 amRNSChange of Registered Office
18th May 20214:36 pmRNSPrice Monitoring Extension
13th May 20213:32 pmRNSFinal Dividend for the year ended 31 December 2020
12th May 20214:20 pmRNSResult of AGM
29th Apr 20217:00 amRNSFirst Quarter 2021 Update
9th Apr 20217:00 amRNSAnnual Financial Report
31st Mar 20214:41 pmRNSSecond Price Monitoring Extn
31st Mar 20214:35 pmRNSPrice Monitoring Extension
12th Mar 20217:09 amRNSFinal Results for the Year Ended 31 December 2020
2nd Mar 20214:41 pmRNSSecond Price Monitoring Extn
2nd Mar 20214:36 pmRNSPrice Monitoring Extension
2nd Feb 20217:00 amRNSNAV and Portfolio Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.